Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.34B | 22.25B | 21.83B | 16.56B | 6.40B | 5.83B |
Gross Profit | 4.57B | 5.46B | 6.15B | 2.80B | -1.62B | -2.31B |
EBITDA | 2.67B | 3.04B | 4.83B | 1.00B | -1.65B | -2.39B |
Net Income | 1.48B | 1.72B | 2.28B | -1.70B | -3.60B | -4.65B |
Balance Sheet | ||||||
Total Assets | 31.15B | 31.21B | 30.20B | 29.51B | 30.61B | 28.91B |
Cash, Cash Equivalents and Short-Term Investments | 6.19B | 6.98B | 8.55B | 7.99B | 8.80B | 7.50B |
Total Debt | 11.79B | 12.67B | 13.86B | 16.31B | 16.52B | 12.99B |
Total Liabilities | 29.36B | 28.82B | 29.40B | 31.06B | 30.61B | 27.20B |
Stockholders Equity | 1.79B | 2.39B | 796.00M | -1.55B | 9.00M | 1.72B |
Cash Flow | ||||||
Free Cash Flow | 801.00M | 1.29B | 2.76B | 796.00M | -2.64B | -3.56B |
Operating Cash Flow | 3.83B | 3.93B | 4.32B | 2.37B | -1.56B | -2.35B |
Investing Cash Flow | -881.00M | -1.36B | -1.83B | -2.50B | -1.87B | -733.00M |
Financing Cash Flow | -2.64B | -2.87B | -2.37B | -1.61B | 4.01B | 4.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $5.72B | 4.67 | 101.32% | ― | 0.33% | -15.99% | |
58 Neutral | HK$13.23B | 4.28 | -2.97% | 5.82% | 2.91% | -48.85% | |
― | $9.17B | 31.55 | 8.87% | ― | ― | ― | |
― | $11.98B | 26.29 | ― | ― | ― | ||
70 Outperform | C$974.21M | 24.36 | 5.12% | 0.73% | 8.59% | 242.80% | |
59 Neutral | C$533.33M | ― | 2.81% | 0.39% | -16.92% | 77.04% | |
― | $1.15B | 11.31 | 19.73% | 1.35% | ― | ― |